Moreover, because some of the same diseases such as cancer are thought to be amenable to treatment by both rexinoids and vitamin D, we explore the relationship between VDR and RXR ligands and their potential cross-talk [28], as well as examine the presence of a multi-ligand pathway that may facilitate synergistic activation of VDR signaling. The gene discussed is VDR; the disease is cancer.